Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Metric	ARGXargenx SE	REGNRegeneron Pharmaceuticals	ONCBeOne Medicines AG
Snapshot
Price	$873.24	$675.10	$316.66
Market cap	$55.53B	$68.59B	$33.43B
Valuation
P/E	26x	15.9x	71.9x
Forward P/E	18.6x	15.3x	—
Growth
Revenue growth	80.6%	5.9%	36.2%
EPS growth	111.4%	4.4%	—
Profitability
Net margin	48.2%	29.6%	7.8%
ROE	22.9%	14.3%	5.2%
Balance sheet & cash
Debt / equity	0.01x	0.09x	0.25x
Free cash flow yield	—	6.3%	—
Dividend yield	—	0.6%	—
Verdict
Investment rating	Strong· 88	Favorable· 69	Neutral· 48

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

Year	ARGXtoday $873	REGNtoday $675	ONCtoday $317
2027	$1,384.65 – $2,030.82+133% CAGR	$528.60 – $775.28+15% CAGR	$323.42 – $474.35+50% CAGR
2028	$2,927.43 – $4,293.57+122% CAGR	$551.86 – $809.40+9% CAGR	$440.43 – $645.97+43% CAGR
2029	$6,189.18 – $9,077.46+118% CAGR	$576.14 – $845.01+8% CAGR	$599.78 – $879.68+41% CAGR
2030	$13,085.16 – $19,191.57+117% CAGR	$601.49 – $882.19+7% CAGR	$816.79 – $1,197.95+39% CAGR
2031	$27,664.65 – $40,574.82+115% CAGR	$627.96 – $921.01+6% CAGR	$1,112.30 – $1,631.37+39% CAGR
5-yr CAGR	99.6% – 115.5%	-1.4% – 6.4%	28.6% – 38.8%